掌閲科技(603533.SH)漲7% 獲百度7億元戰略入股
格隆匯4月3日丨掌閲科技(603533.SH)今日大漲7.33%報21.24元,暫成交3.22億元,最新總市值85億元。據悉,掌閲是市場上用户基數最大的閲讀應用,按該公司19年半年報披露水平,現在月活的用户量水平到了1.2億以上。掌閲科技近日獲百度7億元入股。3月17日,掌閲科技發佈了一項非公開發行的預案,擬發行股份募集7億元用於版權採購與版權加工,百度關聯方百瑞翔(達孜縣百瑞翔創業投資管理有限責任公司)全額認購,發行後百瑞翔將成為掌閲科技第三大股東,持股比例僅在其實際控制人張凌雲、成湘均之後。格隆匯平台昨日發佈深度分析文章《終究內容為王?掌閲科技攜手百度斬“最高級流量”,再踏新徵程》,可點擊下列鏈接詳細瞭解。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.